The mTOR inhibitor that has anti-aging researchers paying very close attention. Originally an immunosuppressant, now studied for its remarkable effects on lifespan extension across every organism tested. The most promising longevity drug in clinical research.
Rapamycin inhibits mTOR (mechanistic target of rapamycin), the master regulator of cellular growth. By suppressing mTORC1, rapamycin shifts cells from anabolic growth mode into catabolic maintenance and repair—the cellular state associated with longevity across species.
Rapamycin is the most studied longevity drug across model organisms. From yeast to mice to primates, consistent lifespan extension has been documented. In mice, the NIA Intervention Testing Program showed 9–14% lifespan extension—one of the largest effects of any single intervention.
Book a consultation with a licensed physician to discuss whether rapamycin is appropriate for your longevity protocol.